Celldex Therapeutics DSO Ratio 2011-2026 | CLDX

Annual DSO Ratio Celldex Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
321	86.5	78.9	40.2	77.5	69.3	104	121	53.8	96	64.6	43.5	43.4	1.43	6.7

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
321	1.43	80.5

Quarterly DSO Ratio Celldex Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	72.1	116	-	34.1	76.8	1.55 K	-	11.1	244	78.4	-	32.1	95.2	109	-	207	30.5	242	43.4	246	697	47.1	104	170	130	134	164	307	104	56.5	49.6	43.7	44.8	109	86.9	73.3	117	96.4	49.5	86.3	40.6	131	26.4	35.4	65.8	100	72	45.5	460	10.1	1.1	1.29	2	4.01	6.38	6.56	7.95	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.55 K	1.1	130

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Arbutus Biopharma Corporation ABUS	50	$ 4.5	0.45 %	$ 862 M	Canada
Agenus AGEN	3.58	$ 3.64	9.31 %	$ 108 M	USA
Agios Pharmaceuticals AGIO	47.4	$ 35.08	-0.36 %	$ 2.03 B	USA
Akebia Therapeutics AKBA	62.9	$ 1.39	0.36 %	$ 357 M	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Alnylam Pharmaceuticals ALNY	58.1	$ 331.14	3.85 %	$ 43.4 B	USA
Altimmune ALT	7.85 K	$ 3.4	1.8 %	$ 300 M	USA
Amgen AMGN	81.2	$ 344.03	-1.12 %	$ 185 B	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Amneal Pharmaceuticals AMRX	55.7	$ 12.27	-1.68 %	$ 3.85 B	USA
Anika Therapeutics ANIK	77.3	$ 14.99	1.28 %	$ 220 M	USA
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
ANI Pharmaceuticals ANIP	114	$ 73.8	-0.55 %	$ 1.43 B	USA
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Aptorum Group Limited APM	20.6	$ 0.88	-5.16 %	$ 4.8 M	China
Aquestive Therapeutics AQST	103	$ 4.12	-0.24 %	$ 441 M	USA
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Arcturus Therapeutics Holdings ARCT	21.2	$ 8.14	1.31 %	$ 223 M	Israel
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
Ardelyx ARDX	58	$ 5.99	0.84 %	$ 1.44 B	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
Arcutis Biotherapeutics ARQT	106	$ 24.06	1.82 %	$ 3.06 B	USA
Arvinas ARVN	4.66	$ 10.87	0.14 %	$ 771 M	USA
Arrowhead Pharmaceuticals ARWR	8.75	$ 60.28	-1.23 %	$ 8.06 B	USA
Assembly Biosciences ASMB	25.1	$ 29.51	1.72 %	$ 331 M	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Alterity Therapeutics Limited ATHE	16.2 K	$ 3.62	1.82 %	$ 8.71 B	Australia